CompletedNot Applicable

Coagulation Disturbances in COVID-19 Septic Patients

Bosnia and Herzegovina100 participantsStarted 2021-01-01

Plain-language summary

Objective of this study was to determine the relationship between CAC and septic condition in COVID-19 critically ill patients. Data including age, sex, comorbidities, quick Sequential Organ Failure Assessment (qSOFA) score, vasopressors requirement, laboratory findings: platelets, neutrophils, lymphocytes, procalcitonin (PCT), C-reactive protein (CRP), fibrinogen, D-dimer, sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC) score were recorded on the day of admission and on the day of starting of invasive mechanical ventilation. Primary outcome was to establish CAC with sepsis; secondary outcome measure was incidence of CAC in sepsis and septic shock in COVID-19 critically ill patients.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all adult critically ill patients tested positive for reverse transcriptase polymerase chain reaction (RT-PCR) of nasopharyngeal swabs to coronavirus 2 (SARS-CoV-2) * patienets admitted to the ICU and presented with acute hypoxemic respirator failure Exclusion Criteria: * patients younger than 18, * immunodeficient patients, * patients with a history of malignancies, * patients who developed septic state before admission, * patients with a history of previous coagulopathy, liver and platelet disease.

What they're measuring

Number of patients with coagulation disorder

Timeframe: 1 year

Trial details

NCT IDNCT05496816

SponsorCantonal Hospital Zenica

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Coagulation Disorder trials